DSKX SEC Filings - DS Healthcare Group, Inc.- Annual Report, Proxy Statement, Prospectus

Basic Stats

CIK

1463959

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to DS Healthcare Group, Inc.

SEC Filings (Chronological Order)

This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.

July 27, 2018	15-12B	DSKX / DS Healthcare Group, Inc. CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
July 16, 2018	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 10, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio
July 10, 2018	EX-99.(A)(1)(XI)	Press Release issued by Medilogistics Corp., issued on July 10, 2018. Press Release EXHIBIT (a)(1)(xi) MEDILOGISTICS CORP. ANNOUNCES EXPIRATION OF SUBSEQUENT OFFERING PERIOD AND FINAL RESULTS OF OFFER MIAMI, Fla., July 10, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont, announced the final results of, and expiration o
July 10, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 9) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go
June 25, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 8) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer
June 25, 2018	EX-99.(A)(1)(X)	Press Release issued by Medilogistics Corp., issued on June 25, 2018. Press Release EXHIBIT (a)(1)(x) MEDILOGISTICS CORP. ANNOUNCES EXPIRATION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK AND COMMENCEMENT OF SUBSEQUENT OFFERING PERIOD MIAMI, Fla., June 25, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Mig
June 21, 2018	EX-99.(D)(1)(VI)	Promissory Note, dated as of June 18, 2018, by and between DS Healthcare Group, Inc. and Fernando Tamez Gutierrez. PROMISSORY NOTE EXHIBIT (d)(1)(vi) PROMISSORY NOTE $10,500 USD June 18, 2018 This Promissory Note (“Note”) is made and entered into by DS Healthcare Group, Inc.
June 21, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 7) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go
June 19, 2018	SC 14D9/A	DSKX / DS Healthcare Group, Inc. SC 14D9/A SC 14D-9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of Clas
June 18, 2018	SC 14D9/A	DSKX / DS Healthcare Group, Inc. SC 14D9/A SC 14D-9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of Clas
June 12, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 6) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer
June 12, 2018	EX-99.(A)(1)(IX)	Press Release issued by Medilogistics Corp., issued on June 12, 2018. Press Release EXHIBIT (a)(1)(ix) MEDILOGISTICS CORP. ANNOUNCES EXTENSION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., June 12, 2018 — Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidders”), in c
June 6, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 5) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go
June 6, 2018	EX-99.(A)(1)(VII)	Press Release issued by Medilogistics Corp., issued on June 6, 2018. Press Release EXHIBIT (a)(1)(viii) MEDILOGISTICS CORP. ANNOUNCES EXTENSION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., June 6, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidders”), in c
June 1, 2018	SC 14D9/A	DSKX / DS Healthcare Group, Inc. SC 14D9/A SC 14D9/A 1 dskx14d9.htm SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001
May 30, 2018	SC 14D9	DSKX / DS Healthcare Group, Inc. SC 14D9 SC 14D9 1 dskx14d9.htm SC 14D9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Subject Company) DS HEALTHCARE GROUP, INC. (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of Cla
May 30, 2018	EX-99.B	Exhibit B (Forms 8K filed by the Board in support of its Rejection of the Offer) EXHIBIT B EXHIBIT B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 30, 2018	EX-99.A	Exhibit A (Amended Offer and Transmittal Letter) Exhibit A EXHIBIT A OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC.
May 29, 2018	EX-99.(A)(1)(VII)	Press Release issued by Medilogistics Corp., issued on May 29, 2018. Press Release Exhibit (a)(1)(vii) MEDILOGISTICS CORP. ANNOUNCES NEW MINIMUM CONDITION OF THE TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., May 29, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidd
May 29, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 4) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer
May 21, 2018	8-K	Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 10, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
May 21, 2018	EX-99.(A)(1)(I)	Offer to Purchase, dated May 21, 2018. OFFER TO PURCHASE EXHIBIT (a)(1)(i) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC.
May 21, 2018	EX-99.(D)(1)(V)	Form of Contingent Value Rights Agreement. Exhibit (d)(1)(v) FORM OF CONTINGENT VALUE RIGHTS AGREEMENT Table of Contents ARTICLE I FORM OF CONTINGENT VALUE RIGHTS AGREEMENT 1 ARTICLE I DEFINITIONS; INTERPRETATION 1 Section 1.
May 21, 2018	EX-99.(A)(1)(VI)	Press Release issued by Medilogistics Corp., issued on May 21, 2018. Press Release Exhibit (a)(1)(vi) MEDILOGISTICS CORP. ANNOUNCES EXTENSION OF TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., May 21, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont (together, the “Bidders”), in connect
May 21, 2018	EX-99.(A)(1)(II)	Form of Letter of Transmittal (including the Form of Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9). EX-99.(A)(1)(II) 3 gutierrezexa1ii.htm LETTER OF TRANSMITTAL Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. AT $0.07 NET PER SHARE, PLUS ONE CONTINGENT VALUE RIGHT PER SHARE REPRESENTING THE RIGHT TO AN AMOUNT EQUAL TO 80% OF ANY POTENTIAL PROCEEDS FROM A PENDING LAWSUIT BY MEDILOGISTICS CORP., A WHOLLY-OWNED SUBSIDIARY OF MEDILOGISTICS LLC T
May 21, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A 1 gutierrezsctot.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 3) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fer
May 21, 2018	EX-99.(A)(1)(III)	Form of Notice of Guaranteed Delivery. EX-99.(A)(1)(III) 4 gutierrezexa1iii.htm NOTICE OF GUARANTEED DELIVERY Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY FOR TENDER OF SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. AT $0.07 NET PER SHARE, PLUS ONE CONTINGENT VALUE RIGHT PER SHARE REPRESENTING THE RIGHT TO AN AMOUNT EQUAL TO 80% OF ANY POTENTIAL PROCEEDS FROM A PENDING LAWSUIT PURSUANT TO THE OFFER TO PURCHASE, AS AMENDED AND
May 16, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go
May 10, 2018	EX-99.(A)(1)(I)	Offer to Purchase, dated May 9, 2018. OFFER TO PURCHASE EXHIBIT (a)(1)(i) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC.
May 10, 2018	EX-99.(A)(1)(III)	Form of Notice of Guaranteed Delivery. NOTICE OF GUARANTEED DELIVERY Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY FOR TENDER OF SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC.
May 10, 2018	EX-99.(A)(1)(II)	Form of Letter of Transmittal (including the Form of Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9). LETTER OF TRANSMITTAL Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC.
May 10, 2018	SC TO-T/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T/A SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Go
May 7, 2018	8-K	Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
May 7, 2018	425	DSKX / DS Healthcare Group, Inc. CURRENT REPORT (Prospectus) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
April 30, 2018	SC TO-T	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC TO-T SC TO-T SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) MEDILOGISTICS CORP. a wholly-owned subsidiary of MEDILOGISTICS LLC Fernando Tamez Gutierrez Miguel Gomez Mont (Names of F
April 30, 2018	EX-99.(A)(1)(I)	Offer to Purchase, dated April 30, 2018. OFFER TO PURCHASE EXHIBIT (a)(1)(i) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC.
April 30, 2018	EX-99.(D)(1)(IV)	Contribution Agreement, dated as of April 21, 2018, among Medilogistics LLC and Fernando Tamez Gutierrez. CONTRIBUTION AGREEMENT EXHIBIT (d)(1)(iv) CONTRIBUTION AGREEMENT among MEDILOGISTICS LLC and FERNANDO TAMEZ GUTIERREZ dated April 21, 2018 TABLE OF CONTENTS Article I.
April 30, 2018	EX-99.(A)(1)(V)	Press Release issued by Medilogistics Corp., issued on April 30, 2018. Press Release Exhibit (a)(1)(v) MEDILOGISTICS CORP. ANNOUNCES COMMENCEMENT OF TENDER OFFER TO PURCHASE ALL DS HEALTHCARE GROUP, INC. COMMON STOCK MIAMI, Fla., April 30, 2018— Medilogistics Corp., a Florida corporation and wholly-owned subsidiary of Medilogistics LLC, a Delaware limited liability corporation, formed by Fernando Tamez Gutierrez and Miguel Gomez Mont, announced today that it has comm
April 30, 2018	EX-99.(A)(1)(II)	Form of Letter of Transmittal (including the Form of Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9). EX-99.(A)(1)(II) 3 gutierrezexa1ii.htm FORM OF LETTER OF TRANSMITTAL Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC. AT $0.07 NET PER SHARE BY MEDILOGISTICS CORP., A WHOLLY-OWNED SUBSIDIARY OF MEDILOGISTICS LLC THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON MAY 29, 2018, UNLESS THE OFFER IS EXTENDED (SUCH DATE
April 30, 2018	EX-99.(A)(1)(IV)	Summary Advertisement as published on April 30, 2018. Summary Advertisement Exhibit (a)(1)(iv) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below).
April 30, 2018	EX-99.(A)(1)(III)	Form of Notice of Guaranteed Delivery. NOTICE OF GUARANTEED DELIVERY Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY FOR TENDER OF SHARES OF COMMON STOCK OF DS HEALTHCARE GROUP, INC.
April 26, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 10, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati
April 26, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 5, 2018 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio
April 25, 2018	SC TO-C	DSKX / DS Healthcare Group, Inc. SC TO-C SC TO-C 1 gutierrezsctoc.htm SC TO-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 ————————————— DS HEALTHCARE GROUP, INC. (Name of Subject Company (Issuer)) Fernando Tamez Gutierrez Miguel Gomez Mont Medilogistics Corp. a wholly-owned subsidiary of
April 24, 2018	SC 13D/A	Amendment No. 3 to Schedule 13D filed by Fernando Tamez Gutierrez on April 24, 2018 SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1451 Brickell Avenue Unit 2701 Miami, FL 33131 (786) 856-8377 (Name, Address and
April 5, 2018	SC 13D/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC 13D/A Activist Investment SC 13D/A 1 gutierrez13d.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1451 Brickell Avenue Unit 2701 Miami, FL 33131 (786)
April 3, 2018	NT 10-K	DSKX / DS Healthcare Group, Inc. NOTIFICATION OF LATE FILING Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): þ Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: DECEMBER 31, 2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transit
February 1, 2018	EX-1	Addendum to the Stock Purchase and Joint Venture Agreement, dated as of August 11, 2017, by and among DS Healthcare Group, Inc. and Evercare Prohealth Technologies LTD. (incorporated by reference to Amendment No. 1 to the Schedule 13D filed by Fernando Tamez Gutierrez on February 1, 2018). Addendum to the Stock Purchase and Joint Venture Agreement EXHIBIT 1 August 11, 2017 ADDENDUM TO THE STOCK PURCHASE AND JOINT VENTURE AGREEMENT By and among DS Healthcare Group, Inc, And EverCare Prohealth Technologies LTD.
February 1, 2018	SC 13D/A	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC 13D/A Activist Investment SC 13D/A 1 gutierrez13d.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1040 Biscayne Blvd., Unit 1501 Miami, FL 33132 (786)
January 9, 2018	SC 13D	DSKX / DS Healthcare Group, Inc. / Tamez Gutierrez Fernando - SC 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 23336Q109 (CUSIP Number) Fernando Tamez Gutierrez 1040 Biscayne Blvd., Unit 1501 Miami, FL 33132 (786) 856-8377 (Name, Address and Telephone Numb
January 9, 2018	EX-3	Addendum to the Stock Purchase and Joint Venture Agreement EX-3 2 gutierrezex3.htm ADDENDUM TO THE STOCK PURCHASE AND JOINT VENTURE AGREEMENT EXHIBIT 3 August 11, 2017 ADDENDUM TO THE STOCK PURCHASE AND JOINT VENTURE AGREEMENT By and among DS Healthcare Group, Inc, And EverCare Prohealth Technologies LTD. Dated: February 7, 2017 1 PURPOSE The purpose of this Addendum is to define the decentralization of operations and improve the distribution of DS Labora
December 8, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 16, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpor
November 14, 2017	NT 10-Q	DSKX / DS Healthcare Group, Inc. NOTIFICATION OF LATE FILING Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: SEPTEMBER 30, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transi
October 23, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 18, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdic
October 13, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 13, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpora
October 13, 2017	EX-99.1	IN THE CIRCUIT COURT OF THE 17TH JUDICIAL CIRCUIT IN AND FOR BROWARD COUNTY, FLORIDA CIVIL TRIAL DIVISION Notice of Proposed Settlement of Derivitive Class Action EXHIBIT 99.1 IN THE CIRCUIT COURT OF THE 17TH JUDICIAL CIRCUIT IN AND FOR BROWARD COUNTY, FLORIDA CIVIL TRIAL DIVISION HANUL KIM, SAUL JAKUBOWITZ, YAFFA FITTERMAN, JAN SISSENER and ANNE-LOUISE SISSENER, Derivatively On Behalf of DS HEALTHCARE GROUP, INC., Plaintiffs, CASE NO. CACE-17-009773 v. DANIEL KHESIN, RENEE BARCH-NILES, MARK BROCKELMA
October 2, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 30, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organ
September 6, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): Septmber 1, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpora
September 6, 2017	EX-99.1	DS Healthcare Updates Shareholders on State of the Business and an Operational Restructuring Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on State of the Business and an Operational Restructuring POMPANO BEACH, FL / ACCESSWIRE / September 5, 2017 / DS Healthcare Group, Inc. (DSKX) ("DSH? or the "Company") announced today that effective September 1, 2017, we finalized a restructuring of the Joint Venture Agreement with Evercare ProHealth Technologies Ltd. (?ECPT?). Over th
August 15, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 14, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat
August 14, 2017	EX-10.1	Employment Agreement EX-10.1 2 dskxex10z1.htm EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“ Agreement ”) is made and entered into June 30, 2017(the “Execution Date” ), by and between DS HEALTHCARE GROUP, INC. a Florida corporation (collectively, the “ Company ”), and FERNANDO TAMEZ (“ Executive ”). RECITALS WHEREAS, the Company is presently engaged in developing products for skin
August 14, 2017	10-Q	DSKX / DS Healthcare Group, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2017 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP
August 1, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio
July 18, 2017	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 17, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio
June 27, 2017	EX-99.1	DS Healthcare Updates Shareholders on Settlement of Photomedex Lawsuit Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on Settlement of Photomedex Lawsuit POMPANO BEACH, FL / ACCESSWIRE / June 26, 2017 / DS Healthcare Group (DSKX) today announced that it has reached an agreement, effective June 23, 2017, to settle the lawsuit, pending in the United States Federal Court in New York. The suit has been dismissed by the court. The lawsuit had alleged a brea
June 27, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 23, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio
June 5, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 1, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
June 5, 2017	EX-99.3	EX-99.3 Employment Agreement EXHIBIT 99.3
June 5, 2017	EX-99.2	EX-99.2 Employment Agreement EXHIBIT 99.2
June 5, 2017	EX-99.1	DS Healthcare Updates Shareholders on Corporate Changes Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on Corporate Changes POMPANO BEACH, FL / ACCESSWIRE / June 05, 2017 / DS Healthcare Group (DSKX) today announced that Yasuhiro Fujiwara, formerly the Chairman of the Board, has been selected as DS Healthcares new Chief Executive Officer. Mr. Fujiwara will assume the new role effective immediately and will replace Daniel Khesin, who wil
June 5, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 2, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
June 5, 2017	EX-99.1	DS Healthcare Updates Shareholders on Settlement of Class Action Lawsuit Press Release EXHIBIT 99.1 DS Healthcare Updates Shareholders on Settlement of Class Action Lawsuit POMPANO BEACH, FL / ACCESSWIRE / June 05, 2017 / DS Healthcare Group (DSKX) today announced that it has reached an agreement, effective June 02, 2017, to settle the securities class action and the plaintiffs derivative lawsuits, pending in the United States District Court for the Southern District
May 18, 2017	8-K	DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 16, 2017 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
May 15, 2017	10-Q	DS Healthcare Group QUARTERLY REPORT (Quarterly Report) Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2017 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROU
May 15, 2017	EX-10.1	STOCK PURCHASE AND JOINT VENTURE AGREEMENT By and among DS Healthcare Group, Inc, EverCare Prohealth Technologies LTD. Dated: February 7, 2017 STOCK PURCHASE AND JOINT VENTURE AGREEMENT STOCK PURCHASE AND JOINT VENTURE AGREEMENT EXHIBIT 10.1 STOCK PURCHASE AND JOINT VENTURE AGREEMENT By and among DS Healthcare Group, Inc, And EverCare Prohealth Technologies LTD. Dated: February 7, 2017 STOCK PURCHASE AND JOINT VENTURE AGREEMENT STOCK PURCHASE AND JOINT VENTURE AGREEMENT, dated and effective as of January 31, 2017 (this Agreement), by and among DS Healthcare Group, Inc., a Flori
March 31, 2017	10-K	DS Healthcare Group ANNUAL REPORT (Annual Report) Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ??????? DS Healthcare Group
February 14, 2017	SC 13G/A	DS Healthcare Group SC 13G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A 1 d327013dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Rule 13d-102) Amendment No. 2 INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) DS Healthcare Group, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 23336Q109 (C
December 29, 2016	8-K	Financial Statements and Exhibits, Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 21, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpor
December 29, 2016	EX-99.1	DS Healthcare Trading Halt Update EXHIBIT 99.1 DS Healthcare Trading Halt Update POMPANO BEACH, Fla., December 29, 2016 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (DSKX) (DS Healthcare or the Company") announce today that on December 21, 2016, DS Healthcare received notice from the Nasdaq Stock Market that its appeal of the delisting notification received on September 16, 2016 was rejected. After careful consideration, the Co
December 21, 2016	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 21, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpor
November 9, 2016	10-Q	DS Healthcare Group QUARTERLY REPORT (Quarterly Report) Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2016 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE
October 18, 2016	10-Q/A	DS Healthcare Group AMENDED QUARTERLY REPORT (Quarterly Report) Amended Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS H
October 18, 2016	10-Q/A	DS Healthcare Group AMENDED QUARTERLY REPORT (Quarterly Report) Amended Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTH
October 14, 2016	10-Q/A	DS Healthcare Group QUARTERLY REPORT (Quarterly Report) Amended Quarterly Report U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALT
October 7, 2016	10-Q	DS Healthcare Group FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2016 (Quarterly Report) U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (mark one) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2016 ? Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact nam
October 7, 2016	10-Q	DS Healthcare Group FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 (Quarterly Report) 10-Q 1 dskx19010q.htm FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (mark one) ☑ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2016 ☐ Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to
October 7, 2016	10-K	DS Healthcare Group ANNUAL REPORT (Annual Report) 10-K 1 dskx10k.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ———————
October 7, 2016	8-K	DS Healthcare Group (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 28, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction (Commission File (I.R.S. E
September 23, 2016	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 16, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorpo
September 23, 2016	EX-99.1	DS Receives Staff Determination Letter From NASDAQ Press Release EXHIBIT 99.1 DS Receives Staff Determination Letter From NASDAQ September 21, 2016 Company Will Appeal Denial of 180 Day Extension Period POMPANO BEACH, FL / ACCESSWIRE / September 21, 2016 / On September 16th, 2016, DS Healthcare Group (DSKX) received a letter from the NASDAQ Market informing the company of its decision to delist the Company's securities due to perceived violations
September 12, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 12, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organ
August 26, 2016	8-K	Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 26, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat
August 26, 2016	8-K	Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 26, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat
August 24, 2016	EX-16.1	August 18, 2016 Auditor Letter EXHIBIT 16.1 August 18, 2016 U.S. Securities and Exchange Commission 100 Fifth Street, N.E. Washington, DC 20549 We have read the statements made by DS Healthcare Group, Inc. (?the Company?) under Item 4.01 of its Form 8-K dated August 16, 2016. We agree with the statements concerning our Firm in such Form 8-K, except that we would add that during the course of our audit, we determi
August 24, 2016	8-K	DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat
August 24, 2016	8-K	DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat
August 24, 2016	EX-16.1	August 18, 2016 Auditor Letter EXHIBIT 16.1 August 18, 2016 U.S. Securities and Exchange Commission 100 Fifth Street, N.E. Washington, DC 20549 We have read the statements made by DS Healthcare Group, Inc. (?the Company?) under Item 4.01 of its Form 8-K dated August 16, 2016. We agree with the statements concerning our Firm in such Form 8-K, except that we would add that during the course of our audit, we determi
August 16, 2016	8-K	Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporat
July 5, 2016	SC 13D/A	DSKX / DS Healthcare Group, Inc. / Khesin Daniel - SC 13D AMENDMENT NO. 1 Activist Investment SC 13D/A 1 khesinsc13d.htm SC 13D AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— SCHEDULE 13D ——————— Under the Securities Exchange Act of 1934 (Amendment No. 1)* DS Healthcare Group, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 23336Q109 (CUSIP Number) Daniel Khesin, 17689 Middlebrook Way, Boca Raton, FL 33496 – (347) 276-259 (
July 5, 2016	EX-1.A	Boca Raton \| Denver \| Ft. Lauderdale \| Las Vegas \| Miami \| Miami Beach \| Naples \| New York Orlando \| Port St. Lucie \| San Diego \| Tallahassee \| Tampa \| West Palm Beach Termination Notice EXHIBIT A From the desk of: Rose Schindler, Esq. One Boca Place, Suite 400-E 2255 Glades Road Boca Raton, Florida 33431 Phone: 561.994.2212 Fax: 561.997.8494 Email: [email protected] June 28, 2016 Re: Termination of Voting Agreement Dear Shareholders: Daniel is providing the following notification to all shareholders who granted him voting authority over their shares of D
June 1, 2016	8-K	DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
May 6, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation
May 6, 2016	EX-16.1	May 6, 2016 Letter EXHIBIT 16.1 May 6, 2016 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by DS Healthcare Group, Inc. under Item 4.01 of its Form 8-K dated May 2, 2016. We agree with the statements concerning our Firm in such Form 8-K. We are not in a position to agree or disagree with other statements of DS Healthcare Group, Inc. c
May 6, 2016	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organization
April 26, 2016	8-K	DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 20, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati
April 22, 2016	EX-1	UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA CASE NO. 16-60661-CIV-DIMITROULEAS ORDER GRANTING MOTION TO TERMINATE EXHIBIT 1 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA CASE NO.
April 22, 2016	SC 14F1	DS Healthcare Group INFORMATION STATEMENT SC 14F1 1 dskx14f1.htm INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14f-1 INFORMATION STATEMENT PURSUANT TO SECTION 14f OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER DS Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Florida 333-195344 20-8380461 (State or other jurisdiction of (Commission Fi
April 15, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 14, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati
April 14, 2016	8-K	Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 14, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati
April 6, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 31, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati
April 4, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 2, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporatio
April 4, 2016	EX-99.1	DS Healthcare Calls For Federal Government to Take Action to Protect Shareholders Press Release Exhibit 99.1 Press Release DS Healthcare Calls For Federal Government to Take Action to Protect Shareholders Published: Apr 3, 2016 9:30 p.m. ET Terminated President Violated Federal Securities Laws and Unlawfully Seized Control of the Company; Chief Financial Officer Steps Down POMPANO BEACH, Fla., Apr 03, 2016 (BUSINESS WIRE) - The board and management of DS Healthcare Group (?DS H
April 4, 2016	DEFN14A	DS Healthcare Group DEFINITIVE PROXY STATEMENT Schedule 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant Filed by Party other than Registrant ? Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)
March 31, 2016	SC 13D	DSKX / DS Healthcare Group, Inc. / Khesin Daniel - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— SCHEDULE 13D ——————— Under the Securities Exchange Act of 1934 (Amendment No. )* DS Healthcare Group, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 23336Q109 (CUSIP Number) Daniel Khesin, 17689 Middlebrook Way, Boca Raton, FL 33496 – (347) 276-259 (Name, Address and Telephone Number of Person
March 31, 2016	EX-99.B	EX-99.B EX-99.B 3 sc13dexhibitb.htm AGREEMENTS OF SHAREHOLDERS TO TRANSFER VOTING AUTHORITY EXHIBIT B
March 31, 2016	EX-99.A	Number of Shares List of Transactions EXHIBIT A Person Reporting Date of Transaction Title of Class Number of Shares Daniel Khesin March 29, 2016 Common Shares 1,075,000 Daniel Khesin March 29, 2016 Common Shares 10,455 Daniel Khesin March 29, 2016 Common Shares 1,274,000 Daniel Khesin March 29, 2016 Common Shares 100,000 Daniel Khesin March 29, 2016 Common Shares 200,000 Daniel Khesin March 29, 2016 Common Shares 271.
March 30, 2016	NT 10-K	DS Healthcare Group NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 28, 2016	8-K	DS Healthcare Group CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 28, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati
March 28, 2016	EX-99.1	DS HEALTHCARE GROUP COMMENTS ON RECENT DEVELOPMENTS EX-99.1 2 dskxex99z1.htm PRESS RELEASE Exhibit 99.1 DS HEALTHCARE GROUP COMMENTS ON RECENT DEVELOPMENTS POMPANO BEACH, Fla., March 28, 2016 (GLOBE NEWSWIRE) – On March 23, 2016, DS Healthcare Group, Inc., a Florida corporation (the “Company”) (NASDAQ:DSKX) filed a Current Report on Form 8-K with the SEC disclosing that the audit committee of the Board of Directors (the “Board”) concluded that the
March 23, 2016	EX-99.1	1601 Green Road Pompano Beach, Florida 33064 EX-99.1 2 dskxex99z1.htm LETTER 1601 Green Road Pompano Beach, Florida 33064 March 17, 2016 Daniel Khesin 17689 Middlebrook Way Boca Raton, FL 33496 Dear Mr. Khesin, Pursuant to Section 4.1(a)(i) of your Employment Agreement dated December 16, 2013, the board of directors of DS HealthCare Group, Inc. (the “Company”) are hereby terminating your employment as an executive officer and employee of the
March 23, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 17, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporati
March 23, 2016	EX-99.2	4651 NORTH FEDERAL HIGHWAY BOCA RATON, FLORIDA 33431-5133 TELEPHONE: (561) 394-8301 FACSIMILE: (561) 394-3121 E-Mail: [email protected] SEC EDGAR FILING
February 25, 2016	8-K/A	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Inc
February 25, 2016	EX-10.3	ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT Form of Articles of Amendment to the Articles of Incorporation Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Business Corporation Act (hereinafter
February 25, 2016	EX-10.3	ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT EX-10.3 2 dskxex10z3.htm CORRECTED FORM OF ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Busine
February 25, 2016	DEFA14A	DS Healthcare Group AMENDED CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Juri
February 22, 2016	EX-10.4	STOCKHOLDERS AGREEMENT DS HEALTHCARE GROUP, INC. RADIANCY, INC. PHOTOMEDEX TECHNOLOGIES, INC. PHOTOMEDEX, INC. Dated: ________ __, 2016 EX-10.4 5 dskxex10z4.htm FORM OF STOCKHOLDERS AGREEMENT Exhibit 10.4 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. RADIANCY, INC. PHOTOMEDEX TECHNOLOGIES, INC. and PHOTOMEDEX, INC. Dated: , 2016 { STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 2016 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc.,
February 22, 2016	EX-10.5	TRANSITION SERVICES AGREEMENT EX-10.5 6 dskxex10z5.htm FORM OF TRANSITION SERVICES AGREEMENT Exhibit 10.5 TRANSITION SERVICES AGREEMENT This TRANSITION SERVICES AGREEMENT (this “Agreement”), dated , 2016 and to be effective as of the 1st day of 2016 (the “Effective Date”), is made and entered into by and between DS Healthcare Group, Inc., a Florida corporation (“DSKX”) and Photomedex, Inc., a Nevada corporation (“PHMD”). RECIT
February 22, 2016	EX-10.2	AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD CONSUMER ACQUISITION CORP. RADIANCY, INC. PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EX-10.2 3 dskxex10z2.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD CONSUMER ACQUISITION CORP. RADIANCY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made as of Februa
February 22, 2016	EX-99.1	DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Business Exhibit 99.1 DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Businesses COMBINATION CREATES A GLOBAL LEADER OF DISRUPTIVE TECHNOLOGIES WITH INDUSTRY’S MOST DIVERSIFIED PRODUCT PORTFOLIO. TRANSACTION WILL GENERATE OVER $60 MILLION IN ADDITIONAL GROSS SALES WITHIN THE FIRST 12 MONTHS. POMPANO BEACH, Fla., February 22, 2016 (GLOBE NEWSWIRE) - DS Healthcare Group,
February 22, 2016	EX-10.6	REGISTRATION RIGHTS AGREEMENT FORM OF REGISTRATION RIGHTS AGREEMENT Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of , 2016, among DS Healthcare Group, Inc., a Florida corporation (the “Company”) and Photomedex, Inc., a Nevada corporation (“PHMD”) and any subsequent PHMD Transferee (together with PHMD, individually and collectively, the “S
February 22, 2016	EX-10.3	ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT Form of Articles of Amendment to the Articles of Incorporation Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Business Corporation Act (hereinafter
February 22, 2016	EX-99.1	DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Business EX-99.1 8 dskxex99z1.htm PRESS RELEASE Exhibit 99.1 DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Businesses COMBINATION CREATES A GLOBAL LEADER OF DISRUPTIVE TECHNOLOGIES WITH INDUSTRY’S MOST DIVERSIFIED PRODUCT PORTFOLIO. TRANSACTION WILL GENERATE OVER $60 MILLION IN ADDITIONAL GROSS SALES WITHIN THE FIRST 12 MONTHS. POMPANO BEACH, Fla., February 22, 2016 (
February 22, 2016	EX-10.1	AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD PROFESSIONAL ACQUISITION CORP. PHOTOMEDEX TECHNOLOGY, INC. PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EX-10.1 2 dskxex10z1.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD PROFESSIONAL ACQUISITION CORP. PHOTOMEDEX TECHNOLOGY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS 1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) i
February 22, 2016	8-K/A	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Juri
February 22, 2016	EX-10.2	AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD CONSUMER ACQUISITION CORP. RADIANCY, INC. PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD CONSUMER ACQUISITION CORP. RADIANCY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made as of February 19, 2016, (the “Execut
February 22, 2016	EX-10.4	STOCKHOLDERS AGREEMENT DS HEALTHCARE GROUP, INC. RADIANCY, INC. PHOTOMEDEX TECHNOLOGIES, INC. PHOTOMEDEX, INC. Dated: ________ __, 2016 EX-10.4 5 dskxex10z4.htm FORM OF STOCKHOLDERS AGREEMENT Exhibit 10.4 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. RADIANCY, INC. PHOTOMEDEX TECHNOLOGIES, INC. and PHOTOMEDEX, INC. Dated: , 2016 { STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 2016 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc.,
February 22, 2016	EX-10.5	TRANSITION SERVICES AGREEMENT FORM OF TRANSITION SERVICES AGREEMENT Exhibit 10.5 TRANSITION SERVICES AGREEMENT This TRANSITION SERVICES AGREEMENT (this “Agreement”), dated , 2016 and to be effective as of the 1st day of 2016 (the “Effective Date”), is made and entered into by and between DS Healthcare Group, Inc., a Florida corporation (“DSKX”) and Photomedex, Inc., a Nevada corporation (“PHMD”). RECITALS: WHEREAS, pursuant to
February 22, 2016	EX-10.3	ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT EX-10.3 4 dskxex10z3.htm FORM OF ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF DS HEALTHCARE GROUP, INC. DESIGNATING SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT DS Healthcare Group, Inc., a corporation organized and existing under Florida Business Cor
February 22, 2016	EX-10.1	AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD PROFESSIONAL ACQUISITION CORP. PHOTOMEDEX TECHNOLOGY, INC. PHOTOMEDEX, INC. TABLE OF CONTENTS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among DS HEALTHCARE GROUP, INC., PHMD PROFESSIONAL ACQUISITION CORP. PHOTOMEDEX TECHNOLOGY, INC. and PHOTOMEDEX, INC. TABLE OF CONTENTS 1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made as of February 19,
February 22, 2016	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE G DEFA14A 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jur
February 22, 2016	EX-10.6	REGISTRATION RIGHTS AGREEMENT FORM OF REGISTRATION RIGHTS AGREEMENT Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of , 2016, among DS Healthcare Group, Inc., a Florida corporation (the “Company”) and Photomedex, Inc., a Nevada corporation (“PHMD”) and any subsequent PHMD Transferee (together with PHMD, individually and collectively, the “S
February 22, 2016	DEFA14A	DS Healthcare Group AMENDED CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Juri
February 22, 2016	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or Other Jurisdiction of Incorporation or Organi
February 18, 2016	8-K	Submission of Matters to a Vote of Security Holders Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 11, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorpor
February 5, 2016	SC 13G/A	DSKX / DS Healthcare Group, Inc. / Frigate Ventures LP - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Rule 13d-102) Amendment No.
January 11, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events 8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 5, 2016 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdict
January 11, 2016	EX-10.1	1601 Green Road Pompano Beach, FL 33064 USA Telephone: 888-404-7770 Fax: 646-219-2572 Web: www.dslaboratories.com Employment Letter EXHIBIT 10.1 January 5th, 2016 Dear Mark, It is my pleasure to extend the following offer of full-time employment to you on behalf of DS Healthcare Group, Inc. This offer is contingent upon your satisfactory completion of a pre-employment confidentiality agreement, standard background check and our receipt of your identity/employment eligibility. Title: CFO Reporting Relationship
January 11, 2016	EX-99.1	Miami Dolphins CFO joins DS Healthcare EX-99.1 3 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 Miami Dolphins CFO joins DS Healthcare Pompano Beach, Fla., January 6, 2016 (GLOBE NEWSWIRE) - Mark Brockelman has joined DS Healthcare Group to help scale its innovative organization into a market leading health and wellness powerhouse focused on technologically advanced, consumer-driven personal care solutions. He will oversee all aspects of th
January 8, 2016	DEFR14A	DS Healthcare Group REVISED PROXY STATEMENT Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Under ? 240.
January 5, 2016	SC 13G/A	DSKX / DS Healthcare Group, Inc. / Del Mar Asset Management, LP - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 1) Under the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 23336Q109 (CUSIP Number) December 24, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi
January 5, 2016	EX-99.1	JOINT FILING AGREEMENT EX-99.1 2 d113175dex991.htm EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.001 par value, of DS Healthcare Group, Inc., a Florida corpor
January 5, 2016	SC 13G	DSKX / DS Healthcare Group, Inc. / Frigate Ventures LP - SC 13G Passive Investment SC 13G 1 d113175dsc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) DS Healthcare Group Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 23336Q109 (CUSIP Number) December 17
December 31, 2015	DEF 14A	DS Healthcare Group PROXY STATEMENT Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Under ? 240.
December 30, 2015	EX-10.4	EXECUTIVE EMPLOYMENT AGREEMENT EXHIBIT 10.4 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (the ?Agreement?) is entered into this day of 2016 (the ?Effective Date?), by and among DS HEALTHCARE GROUP, INC., a Florida corporation (?DSH?); W/R GROUP, INC. (formerly, WRG Acquisition Corporation), a corporation organized under the laws of the laws of the State of Arizona, (the ?Company?); and CAREY WILLIAMS, an i
December 30, 2015	EX-10.5	[Remainder of page intentionally left blank.] EX-10.5 6 dskxex10z5.htm FINANCING LETTER CONFIDENTIAL - NOT A COMMITMENT EXHIBIT 10.5 December 28, 2015 DS Healthcare Group, Inc. 1601 Green Road Pompano Beach, FL 33064 Ladies and Gentlemen: You have advised White Oak Global Advisors, LLC (“White Oak” or "we") that DS Healthcare Group, Inc., a Florida corporation (“DSH” or “you”) has entered into an Amended and Restated Asset Purchase Agreement
December 30, 2015	EX-10.3	STOCKHOLDERS AGREEMENT DS HEALTHCARE GROUP, INC. CAREY WILLIAMS STEFAN RUSSELL Dated: ________ __, 201_ STOCKHOLDERS AGREEMENT EX-10.3 4 dskxex10z3.htm FORM OF STOCKHOLDERS AGREEMENT EXHIBIT 10.3 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. CAREY WILLIAMS and STEFAN RUSSELL Dated: , 201 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 201 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc., a Florida corporation (“DSH” or the
December 30, 2015	EX-10.2	AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER AND REORGANIZATION DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. STEFAN RUSSELL, As of DECEMBER 23, 2015 TABLE OF CONTENTS Amended and Restated Merger Agreement EXHIBIT 10.2 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. AND STEFAN RUSSELL, As of DECEMBER 23, 2015 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 The Closing 2 1.3 Actions at the Closing 2 1.4 Additional Actions 3 1.5 Conversion of Company Comm
December 30, 2015	EX-10.1	AMENDED AND RESTATED ASSET PURCHASE AGREEMENT DS HEALTHCARE GROUP, INC., WRG ACQUISITION CORPORATION W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, CAREY WILLIAMS As of DECEMBER 23, 2015 TABLE OF CONTENTS EX-10.1 2 dskxex10z1.htm AMENDED AND RESTATED ASSET PURCHASE AGREEMENT EXHIBIT 10.1 AMENDED AND RESTATED ASSET PURCHASE AGREEMENT AMONG DS HEALTHCARE GROUP, INC., WRG ACQUISITION CORPORATION W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, AND CAREY WILLIAMS As of DECEMBER 23, 2015 TABLE OF CONTENTS BACKGROUND 1 ARTICLE I – SALE AND PURCHASE OF ASSETS 2 Section 1.1 Purchased Assets 2 Secti
December 30, 2015	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 23, 2015 DS HEALTHCARE G Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 23, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorpor
December 29, 2015	8-K/A	DS Healthcare Group AMENDED CURRENT REPORT (Current Report/Significant Event) Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment Number 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 17, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other j
December 22, 2015	424B5	2,000,000 Shares of Common Stock DS HEALTHCARE GROUP, INC. Prospectus Supplement Filed Pursuant to Rule 424(b)(5) Registration No. 333-195344 PROSPECTUS SUPPLEMENT (To the Prospectus Dated July 25, 2014) 2,000,000 Shares of Common Stock DS HEALTHCARE GROUP, INC. We are offering 2,000,000 shares of our common stock, $0.001 par value per share, to selected investors pursuant to this prospectus supplement and the accompanying prospectus and a securities purc
December 21, 2015	EX-10.1	Exhibit 10.1 EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this Agreement) is dated as of December 17, 2015, between DS Healthcare Group, Inc., a Florida corporation (the Company), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a Purchaser and collectively the Purchasers). WHEREAS, subject to the terms and condit
December 21, 2015	EX-4.1	Exhibit 4.1 Form of Warrant EXHIBIT 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN E
December 21, 2015	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 17, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpor
December 21, 2015	EX-99.1	DS Healthcare Announces $5 Million Registered Direct Offering to Finalize Senior Debt Requirements EX-99.1 6 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 DS Healthcare Announces $5 Million Registered Direct Offering to Finalize Senior Debt Requirements Pompano Beach Fla., Dec. 18, 2015 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (Nasdaq:DSKX) (the "Company" or "DSKX") announced that it entered into a definitive securities purchase agreement with certain institutional investors for the issuance of
December 21, 2015	EX-10.2	Exhibit 10.2 Engagement Letter with Placement Agent EXHIBIT 10.2 December 16, 2015 STRICTLY CONFIDENTIAL Abner Silva Chief Operating Officer DS Healthcare Group, Inc. 1601 Green Road Pompano Beach FL 33064 Dear Mr. Silva: This letter agreement (this Agreement) constitutes the agreement between DS Healthcare Group, Inc. (the Company) and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC (Rodman), a b
December 21, 2015	EX-10.3	Exhibit 10.3 EXHIBIT 10.3 December 18, 2015 STRICTLY CONFIDENTIAL DS Healthcare Group, Inc. 1601 Green Road Pompano Beach FL 33064 Attn: Abner Silva Dear Mr. Silva Reference is made to the engagement letter (the Engagement Letter), dated December 16, 2015 by and between DS Healthcare Group, Inc. (the Company) and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC (Rodman),. Defined terms used herein
November 16, 2015	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 o Transition report under Sectio U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exac
October 27, 2015	EX-10.1	EMPLOYMENT AGREEMENT EX-10.1 2 dskxex10z1.htm EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into by and between DS HEALTHCARE GROUP, INC., (NASDAQ: DSKX) (a.k.a. DS Laboratories) Headquartered in Pompano Beach, Florida, a Florida corporation (the “Company”), and RENEE BARCH-NILES (the “Executive”), on this 26th day of October, 2015. RECITALS WHER
October 27, 2015	EX-99.1	DS Healthcare Names Renee Barch-Niles Chief Executive Officer Press Release EXHIBIT 99.1 DS Healthcare Names Renee Barch-Niles Chief Executive Officer Pompano Beach, Fla., Oct. 26, 2015 - DS Healthcare Group, Inc. (DSKX) today announced that Renee Barch-Niles has been named Chief Executive Officer. Barch-Niles succeeds Daniel Khesin, DS Healthcare?s founding CEO. Khesin will continue to serve as Chairman and will lead product innovation. Renee Barch-Niles ha
October 27, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpora
October 16, 2015	8-K	Regulation FD Disclosure, Financial Statements and Exhibits Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpora
October 16, 2015	EX-99.1	Company executes term sheet for $35 million debt facility Press Release Exhibit 99.1 DS HEALTHCARE PROVIDES UPDATE ON WR GROUP ACQUISITION. Company executes term sheet for $35 million debt facility Pompano Beach, Fla., October 16, 2015 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (NASDAQ:DSKX) (?DS Healthcare? or the "Company") announced here today that it has executed a term sheet with a middle market lender which will provide the Company with $35 milli
September 29, 2015	EX-10.3	STOCKHOLDERS AGREEMENT DS HEALTHCARE GROUP, INC. CAREY WILLIAMS STEFAN RUSSELL Dated: ________ __, 2015 STOCKHOLDERS AGREEMENT Form of Stockholders Agreement EXHIBIT 10.3 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. CAREY WILLIAMS and STEFAN RUSSELL Dated: , 2015 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this Agreement), to be effective as of [*], 2015 (the Effective Date) is made and entered into by and among (A) DS Healthcare Group, Inc., a Florida corporation (DSH or the Corporation); (B) St
September 29, 2015	EX-10.2	AGREEMENT AND PLAN OF MERGER AND REORGANIZATION DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. STEFAN RUSSELL, As of AUGUST 31, 2015 TABLE OF CONTENTS EX-10.2 3 dskxex10z2.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. AND STEFAN RUSSELL, As of AUGUST 31, 2015 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 The Closing 2 1.3 Actions at the Closing 2 1.4 Additional Actions 3 1.5 Conversion of
September 29, 2015	EX-10.1	ASSET PURCHASE AGREEMENT DS HEALTHCARE GROUP, INC., WRG ACQUISITION CORPORATION W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, CAREY WILLIAMS As of AUGUST 31, 2015 TABLE OF CONTENTS EX-10.1 2 dskxex10z1.htm ASSET PURCHASE AGREEMENT EXHIBIT 10.1 ASSET PURCHASE AGREEMENT AMONG DS HEALTHCARE GROUP, INC., WRG ACQUISITION CORPORATION W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, AND CAREY WILLIAMS As of AUGUST 31, 2015 TABLE OF CONTENTS BACKGROUND 1 ARTICLE I – SALE AND PURCHASE OF ASSETS 2 Section 1.1 Purchased Assets 2 Section 1.2 Excluded Assets 4 Section 1.3 Assumed
September 29, 2015	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 24, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorpo
August 17, 2015	EX-99.1	DS HEALTHCARE ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE WR GROUP Press Release EXHIBIT 99.1 DS HEALTHCARE ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE WR GROUP Combined business expected to have approximately $65 million in annual revenues and $10 million in EBITDA from over 20 countries, 900 unique and diversified products, and a broad range of personal care categories. Resulting synergies provide a platform for rapid growth. Pompano Beach, Fla., August 17, 201
August 17, 2015	EX-10.1	STOCK PURCHASE AGREEMENT DS HEALTHCARE, INC., W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, CAREY WILLIAMS As of JULY 31, 2015 TABLE OF CONTENTS Stock Purchase Agreement EXHIBIT 10.1 STOCK PURCHASE AGREEMENT AMONG DS HEALTHCARE, INC., W/R GROUP, INC., WR GROUP IC-DISC, INC., STEFAN RUSSELL, AND CAREY WILLIAMS As of JULY 31, 2015 TABLE OF CONTENTS Page ARTICLE I PURCHASE OF THE SUBJECT SHARES 1 1.1 Sale and Purchase 1 1.2 The Closing 7 1.3 Actions at the Closing 7 1.4 Additional Actions 8 1.12 Transfer Books; Bank Accounts 8 ARTICLE II REPR
August 17, 2015	EX-10.2	AGREEMENT AND PLAN OF MERGER AND REORGANIZATION DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. STEFAN RUSSELL, As of JULY 31, 2015 TABLE OF CONTENTS EX-10.2 3 dskxex10z2.htm AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EXHIBIT 10.2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among DS HEALTHCARE, INC. WRG ACQUISITION CORP. WR GROUP IC-DISC, INC. AND STEFAN RUSSELL, As of JULY 31, 2015 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 The Closing 2 1.3 Actions at the Closing 2 1.4 Additional Actions 3 1.5 Conversion of Co
August 17, 2015	EX-10.3	STOCKHOLDERS AGREEMENT DS HEALTHCARE GROUP, INC. CAREY WILLIAMS STEFAN RUSSELL Dated: ________ __, 2015 STOCKHOLDERS AGREEMENT EX-10.3 4 dskxex10z3.htm FORM OF STOCKHOLDERS AGREEMENT EXHIBIT 10.3 STOCKHOLDERS AGREEMENT Among DS HEALTHCARE GROUP, INC. CAREY WILLIAMS and STEFAN RUSSELL Dated: , 2015 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”), to be effective as of [*], 2015 (the “Effective Date”) is made and entered into by and among (A) DS Healthcare Group, Inc., a Florida corporation (“DSH” or t
August 17, 2015	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 11, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or Other Jurisdiction of Incorporat
August 14, 2015	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 o Transition report under Section 13 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact nam
August 4, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commission
June 9, 2015	CORRESP	DS Healthcare Group ESP DS HEALTHCARE GROUP, INC. 1601 Green Road Pompano Beach, Florida 33064 June 9, 2015 Via EDGAR Securities and Exchange Commission 100 F Street, N.W. Washington, D.C. 20549 Attention: David Korvin Re: DS Healthcare Group, Inc. Registration Statement on Form S-3 Filed June 2, 2015 File No. 333-204651 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, DS Healthcar
June 2, 2015	EX-10.1	CONSULTING AGREEMENT EX-10.1 3 dskxex10z1.htm CONSULTING AGREEMENT EXHIBIT 10.1 CONSULTING AGREEMENT This Consulting Agreement (“Agreement”) is entered into effective as of , 2015 by and between DS Health Care Group, Inc. (the “Company”) and RP Innovative Consulting, LLC (“Consultant”). The Company desires to retain Consultant on a contract basis to perform consulting services for the Company, and Consultant is willin
June 2, 2015	S-3	DS Healthcare Group REGISTRATION STATEMENT S-3 1 dskxs3.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on June 2, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DS Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Florida 20-8380461 (State or other jurisdiction of
May 20, 2015	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2015 o Transition report under Section 13 10-Q 1 dskx10q.htm QUARTERLY REPORT U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2015 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763
May 18, 2015	NT 10-Q	DS Healthcare Group NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 8, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation)
May 1, 2015	S-8	DS Healthcare Group REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on May 1, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
April 30, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdicti
April 16, 2015	EX-99.1	DS Healthcare Group Reports Fourth Quarter and Full Year 2014 Financial Results as Company Reports Its First Profitable Quarter Revenue up 21% in Fourth Quarter From Same Period in 2013 Press Release EXHIBIT 99.1 DS Healthcare Group Reports Fourth Quarter and Full Year 2014 Financial Results as Company Reports Its First Profitable Quarter Revenue up 21% in Fourth Quarter From Same Period in 2013 POMPANO BEACH, Fla., April 15, 2015 (GLOBE NEWSWIRE) - DS Healthcare Group, Inc. (DSKX), "DS Healthcare" or "the Company" a leading developer of personal care products has released financ
April 16, 2015	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commission
April 15, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2014 ¨ TRANSITION REPORT PURSUANT TO SECT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ??????? DS Healthcare Group, Inc. (Exact
April 1, 2015	NT 10-K	DS Healthcare Group NOTIFICATION OF LATE FILING NT 10-K 1 dskx12b25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ü Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: December 31, 2014 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on
January 14, 2015	8-K	Submission of Matters to a Vote of Security Holders Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2015 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorpora
December 31, 2014	DEF 14A	DSKX / DS Healthcare Group, Inc. DEF 14A - - PROXY STATEMENT DEF 14A 1 dskx14a.htm PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy Statement
December 19, 2014	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdi
November 14, 2014	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2014 o Transition report under Sectio U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2014 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exac
August 15, 2014	EX-99.1	DS Healthcare Group Reports Second Quarter 2014 Financial Results Revenues, gross profits, and gross margins increase in Q2 2014 over prior year period EX-99.1 2 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 DS Healthcare Group Reports Second Quarter 2014 Financial Results Revenues, gross profits, and gross margins increase in Q2 2014 over prior year period Pompano Beach, Fla., August 15, 2014 – DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and six months ended
August 15, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 dskx8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdict
August 14, 2014	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2014 o Transition report under Section 13 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2014 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact nam
August 11, 2014	424B3	1,965,000 shares 424B3 1 dskx424b.htm REGISTRATION STATEMENT Filed Pursuant to Rule 424(b)(3) Registration No. 333-195345 PROSPECTUS 1,965,000 shares This prospectus relates to periodic offers and sales of 1,965,000 shares of our common stock by the selling shareholders. These shares may be sold from time to time by the selling shareholder and their donees, pledgees, transferees or successors in interest. These sh
July 31, 2014	CORRESP	DSKX / DS Healthcare Group, Inc. CORRESP - - Acceleration Request DS HEALTHCARE GROUP, INC. 1601 Green Road Pompano Beach, Florida 33064 July 31, 2014 “CORRES” VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549-4631 Re: DS HEALTHCARE GROUP, INC. Registration Statement on Form S-3 File No. 333-195345 Ladies and Gentlemen: The under undersigned registrant hereby
July 31, 2014	CORRESP	DSKX / DS Healthcare Group, Inc. CORRESP - - Acceleration Request DS HEALTHCARE GROUP, INC. 1601 Green Road Pompano Beach, Florida 33064 July 31, 2014 “CORRES” VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549-4631 Re: DS HEALTHCARE GROUP, INC. Registration Statement on Form S-3 File No. 333-195344 Ladies and Gentlemen: The under undersigned registrant hereby
July 25, 2014	S-3/A	DSKX / DS Healthcare Group, Inc. S-3/A - - REGISTRATION STATEMENT Amended Registration Statement As filed with the Securities and Exchange Commission on July 25, 2014 Registration No.
July 15, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorporatio
July 3, 2014	S-3/A	DSKX / DS Healthcare Group, Inc. S-3/A - - REGISTRATION STATEMENT Amended Registration Statement As filed with the Securities and Exchange Commission on July 3, 2014 Registration No.
July 3, 2014	S-3/A	DSKX / DS Healthcare Group, Inc. S-3/A - - REGISTRATION STATEMENT Amended Registration Statement As filed with the Securities and Exchange Commission on July 3, 2014 Registration No.
July 3, 2014	CORRESP	DSKX / DS Healthcare Group, Inc. CORRESP - - Response Letter PEARLMAN SCHNEIDER LLP Attorneys-at-Law 2200 Corporate Boulevard, N.
July 1, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorporation) (Commission
May 15, 2014	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2014 o Transition report under Section 13 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2014 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exact na
April 17, 2014	S-3	- REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on April 17, 2014 Registration No.
April 17, 2014	S-3	- REGISTRATION STATEMENT Registration Statement As filed with the Securities and Exchange Commission on April 17, 2014 Registration No.
April 4, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2013 ¨ TRANSITION REPORT PURSUANT TO SECT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ??????? DS Healthcare Group, Inc. (Exact
April 1, 2014	NT 10-K	- NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 10, 2014	SC 13G/A	DSKX / DS Healthcare Group, Inc. / Phoenix Investment Fund Inc. - SC 13G/A Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 and 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* DS HEALTHCARE GROUP, INC. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 23336Q109 (CUSIP Number) December 31, 2013 (Date of Event which R
January 6, 2014	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2014 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorporat
January 6, 2014	EX-10.2	AMENDMENT AGREEMENT Amendment Agreement EXHIBIT 10.2 AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT (this “Agreement”), dated as of December 30, 2013 is entered into by and between DS HEALTHCARE GROUP, INC., a Florida corporation (the “Company”) and DEL MAR MASTER FUND, LTD. (the “Holder”). Capitalized terms used herein, but not otherwise defined, shall have the meanings ascribed to such terms in the Purchase Agreement
January 6, 2014	EX-99.1	DS Healthcare Group Completes Private Placement of $3,144,000 Dollars EX-99.1 3 dskxex99z1.htm PRESS RELEASE EXHIBIT 99.1 DS Healthcare Group Completes Private Placement of $3,144,000 Dollars Pompano Beach, Jan. 06, 2013 (GLOBE NEWSWIRE) – DS Healthcare Group, Inc. (Nasdaq: DSKX), a developer of personal care products, today announced that it has completed its securities purchase agreement with a group of accredited investors for the sale of 1,965,000 shares of the
December 27, 2013	SC 13G	DSKX / DS Healthcare Group, Inc. / Del Mar Asset Management, LP - SC 13G Passive Investment SC 13G 1 delmar13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 DS HEALTHCARE GROUP, INC. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 23336Q109 (CUSIP Number) December 24, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu
December 26, 2013	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 24, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorpor
December 26, 2013	EX-99.1	DS Healthcare Group Announces Private Placement of $2,420,000 Million Dollars EX-99.1 3 dskxex99z1.htm PRRESS RELEASE EXHIBIT 99.1 DS Healthcare Group Announces Private Placement of $2,420,000 Million Dollars Pompano Beach, Fla., December 25, 2013 – DS Healthcare Group, Inc. (Nasdaq: DSKX), a developer of personal care products, today announced that it entered and consummated a securities purchase agreement with an accredited investor for the sale of 1,512,500 shares of the
December 26, 2013	EX-10.1	SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2013, between DS Healthcare Group, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS,
December 17, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorpor
December 17, 2013	EX-10.1	EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into December 16, 2013 (the “Execution Date”), by and between DS HEALTHCARE GROUP, INC. a Florida corporation (collectively, the “Company”), and DANIEL KHESIN (“Executive”). RECITALS WHEREAS, the Company is presently engaged in developing products for skin care and personal care needs
November 18, 2013	8-K/A	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 001-35763 20-8380461 (State or other jurisdiction of incorpor
November 14, 2013	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2013 o Transition report under Sectio U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2013 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 001-35763 DS HEALTHCARE GROUP, INC. (Exac
November 1, 2013	144	- NOTICE OF PROPOSED SALE OF SECURITIES FORM 144 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0101 Washington, D.
October 31, 2013	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commissi
October 10, 2013	EX-16.1	October 4, 2013 Auditor Letter EXHIBIT 16.1 October 4, 2013 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated October 4, 2013 of DS Healthcare Group, Inc. and are in agreement with the statements contained first sentence with regards to the dismissal of Cherry Bekaert LLP, the second and fourth sentence of the first para
October 10, 2013	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporat
October 10, 2013	DEF 14A	- PROXY STATEMENT Proxy Statement SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
October 9, 2013	EX-99.1	Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS EX-99.1 2 dskx99z1.htm FINANCIAL STATEMENTS EXHIBIT 99.1 Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS Unaudited Balance Sheets as of September 30, 2012 (as restated) and December 31, 2011 (as restated) F-2 Unaudited Statements of Operations for the nine months ended September 30, 2012 (as restated) and 2011 (as restated) F-3 Unaudited Statements of Changes in Shareholders’ E
October 9, 2013	8-K/A	Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 4 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdi
September 20, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2013 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdiction of incorporation) (Commis
August 19, 2013	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2013 o Transition report under Section 13 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended June 30, 2013 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-53680 DS HEALTHCARE GROUP, INC. (Exact nam
August 15, 2013	NT 10-Q	- LATE FILING 10-Q FORM Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
July 25, 2013	EX-99.1	Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS FINANCIAL STATEMENTS EXHIBIT 99.1 Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS Unaudited Balance Sheets as of September 30, 2012 and 2011 F-2 Unaudited Statements of Operations for the nine months ended September 30, 2012 and 2011 F-3 Unaudited Statements of Changes in Shareholders’ Equity for the nine months ended September 30, 2012 and 2011 F-4 Unaudited Statements of Cash
July 25, 2013	8-K/A	Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 3 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdi
July 25, 2013	EX-99.2	DS Healthcare Group, Inc. EX-99.2 3 dskx99z2.htm PROFORMA FINANCIALS EXHIBIT 99.2 DS Healthcare Group, Inc. Pro-Forma Consolidated Balance Sheet September 30, 2012 DS Healthcare Group, Inc. (Consolidated) DS Laboratories, S.A. DE C.V. Acquisition Adjustment Acquisition Adjustment Elimination ProForma Consolidated Balance Sheet ASSETS Current Assets Cash $ 945,065 $ 70,762 $ 1,015,827 Accounts receivable, net 2,575,231 392,
July 19, 2013	RW	- REGISTRATION WITHDRAWAL REQUEST Registration Withdrawal Request DS Healthcare Group, Inc. 1601 Green Road Pompano Beach, Florida 33064 July 19, 2013 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attn: Sherry Haywood Re: Form RW With Respect to Withdrawal of Registration Statement on Form S-1 (File No. 333-183558) Dear Ms. Haywood: Pursuant to Rule 477 pr
June 11, 2013	8-K/A	Financial Statements and Exhibits - CURRENT REPORT Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 2 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 DS HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Florida 000-53680 20-8380461 (State or other jurisdi
June 11, 2013	EX-99.2	DS Healthcare Group, Inc. Pro-Forma EXHIBIT 99.2 DS Healthcare Group, Inc. Pro-Forma Consolidated Balance Sheet September 30, 2012 DS Healthcare Group, Inc. (Consolidated) DS Laboratories, S.A. DE C.V. Acquisition Adjustment Acquisition Adjustment Elimination ProForma Consolidated Balance Sheet ASSETS Current Assets Cash $ 945,065 $ 70,762 $ 1,015,827 Accounts receivable, net 2,575,231 392,323 (255,676 ) (c) 2,711,878 Inve
June 11, 2013	EX-99.1	Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS EX-99.1 2 dskx99z1.htm FINANCIAL STATEMENTS EXHIBIT 99.1 Divine Skin Laboratories S.A. DE C.V. INDEX TO FINANCIAL STATEMENTS Unaudited Balance Sheets as of September 30, 2012 and 2011 F-2 Unaudited Statements of Operations for the nine months ended September 30, 2012 and 2011 F-3 Unaudited Statements of Changes in Shareholders’ Equity for the nine months ended September 30, 2012 and 2011 F-4 Unaud
May 16, 2013	10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2013 o Transition report under Section 13 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (MARK ONE) ? Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended March 31, 2013 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-53680 DS HEALTHCARE GROUP, INC. (Exact na
May 16, 2013	NT 10-Q	- NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
April 30, 2013	10-Q/A	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2012 o Transition report under Sect U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (MARK ONE) þ Quarterly Report Pursuant to Section 13 or 15(d) of Securities Exchange Act of 1934 For the quarterly period ended September 30, 2012 o Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-53680 DS HEALTHCARE GROUP, INC. (Na

DSKX / DS Healthcare Group, Inc. - SEC Filings, Annual Report, Proxy Statement

Basic Stats

SEC Filings

SEC Filings (Chronological Order)